NCT02328053 arm group b54d3ab333c7cd7477b245ccee1b0c71 [clinicaltrials_resource:NCT02328053/arm-group/b54d3ab333c7cd7477b245ccee1b0c71]
arm group [clinicaltrials_vocabulary:arm-group]
NCT02328053 arm group b54d3ab333c7cd7477b245ccee1b0c71 [clinicaltrials_resource:NCT02328053/arm-group/b54d3ab333c7cd7477b245ccee1b0c71]
Bio2RDF identifier
NCT02328053/arm-group/b54d3ab333c7cd7477b245ccee1b0c71
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 4d3ab333c7cd7477b245ccee1b0c71
description [clinicaltrials_vocabulary:description]
patients were continued on top ...... ops and voriconazole eye drops
identifier
clinicaltrials_resource:NCT02328053/arm-group/b54d3ab333c7cd7477b245ccee1b0c71
title
NCT02328053 arm group b54d3ab333c7cd7477b245ccee1b0c71
@en
type
label
NCT02328053 arm group b54d3ab3 ...... d3ab333c7cd7477b245ccee1b0c71]
@en